Skip to content
Screener

Amgen AMGN Q2 2026 earnings

Reported August 4, 2026 · After market close

Revenue$10.1BBeat by $627.8M
Adjusted EPS$6.29Beat by $0.67
Revenue estimate$9.4B
EPS estimate$5.62
“Our results demonstrate strong performance across our business. Our six key growth drivers grew 26% year over year, generating nearly 70% of second-quarter product sales. As we expand the potential of our existing medicines through new indications and advance the next wave of pipeline molecules through Phase 3, we remain confident in our ability to deliver growth well into the next decade.”
Robert A. Bradway

Next report

Nov 3, 2026 (in a month)
Revenue estimate$10.0B
EPS estimate$5.78

Financials

Q2 2026

Income statement

See full
Revenue$10.1B+9.5%
Gross profit$7.2B+17.4%
Operating income$3.5B+32.3%
Net income$2.4B+65.9%
EPS (diluted)$4.37+64.9%

Balance sheet

See full
Cash & equivalents$574.0M+5.9%
Total debt$57.3B+2.0%
Total equity$11.7B+57.4%
Total assets$95.6B+8.8%

Cash flow

See full
Operating cash flow$4.0B+75.5%
CapEx$513.0M+39.0%
Free cash flow$3.5B+82.6%

Valuation & ratios

Valuation

as of 10/02/26
See full
Market cap$220.18B+37.5%
Enterprise value$276.91B+29.4%
P/E25.2×+2.3×
P/S5.8×+1.3×

Profitability

See full
Gross margin69.5%+5.0pp
Operating margin30%+6.5pp
Net margin23%+4.0pp
FCF margin26.7%-3.7pp

Returns & leverage

See full
Return on equity91.5%-7.7pp
Debt / equity4.9×-2.7×
Current ratio1.4×+0.1×

Segments

By product

See full
Other products$1.7B+23.0%
Repatha$953.0M+26.4%
Prolia$759.0M-32.4%
EVENITY$714.0M+37.8%
ENBREL$580.0M-4.0%

By segment

See full
Reportable Segment$10.1B+9.5%

FAQ

When did Amgen report Q2 2026 earnings?
Amgen (AMGN) reported Q2 2026 earnings on August 4, 2026 after market close.
What were Amgen's Q2 2026 revenue and EPS?
Amgen reported revenue of $10.1B and adjusted eps of $6.29 for Q2 2026.
Did Amgen beat estimates in Q2 2026?
Revenue beat the consensus estimate of $9.4B by $627.8M. EPS beat the consensus estimate of $5.62 by $0.67.
How did Amgen's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.7% from $9.2B a year earlier.
Where can I find Amgen's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000318154-26-000124) and the 10-Q periodic report (0000318154-26-000126) directly on SEC EDGAR. The filing index links above go to sec.gov.